Xarelto Versus Aspirin for Extended Treatment of VTE: Rationale and Results of the EINSTEIN CHOICE Trial

This website contains information on Xarelto (rivaroxaban) which is based on the Summary of Product Characteristics (SPC) as approved by the European Commission. It is intended to provide information to an international audience outside the USA and UK.